These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9724789)

  • 1. A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice.
    Shoemaker AR; Moser AR; Midgley CA; Clipson L; Newton MA; Dove WF
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10826-31. PubMed ID: 9724789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice.
    Gould KA; Dietrich WF; Borenstein N; Lander ES; Dove WF
    Genetics; 1996 Dec; 144(4):1769-76. PubMed ID: 8978062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc(+) allele.
    Andreassen A ; Vikse R; Steffensen IL; Paulsen JE; Alexander J
    Mutagenesis; 2001 Jul; 16(4):309-15. PubMed ID: 11420398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
    Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
    Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in spontaneous and X-ray-induced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of APC(+) and Dpc4 in tumor development.
    Haines J; Dunford R; Moody J; Ellender M; Cox R; Silver A
    Genes Chromosomes Cancer; 2000 Aug; 28(4):387-94. PubMed ID: 10862047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic genetic events linked to the Apc locus in intestinal adenomas of the Min mouse.
    Luongo C; Dove WF
    Genes Chromosomes Cancer; 1996 Nov; 17(3):194-8. PubMed ID: 8946200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutational mechanisms involved in intestinal tumor formation in Min mice.
    Shoemaker AR; Luongo C; Moser AR; Marton LJ; Dove WF
    Cancer Res; 1997 May; 57(10):1999-2006. PubMed ID: 9157997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.
    Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR
    Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1370):915-23. PubMed ID: 9684289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.
    Silverman KA; Koratkar R; Siracusa LD; Buchberg AM
    Genome Res; 2002 Jan; 12(1):88-97. PubMed ID: 11779834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
    Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
    Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis.
    Koratkar R; Silverman KA; Pequignot E; Hauck WW; Buchberg AM; Siracusa LD
    Genomics; 2004 Nov; 84(5):844-52. PubMed ID: 15475263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
    Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
    Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApcMin: a mouse model for intestinal and mammary tumorigenesis.
    Moser AR; Luongo C; Gould KA; McNeley MK; Shoemaker AR; Dove WF
    Eur J Cancer; 1995; 31A(7-8):1061-4. PubMed ID: 7576992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenomatous polyposis coli truncation mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumours of multiple intestinal neoplasia mice.
    Møllersen L; Vikse R; Andreassen A; Steffensen IL; Mikalsen A; Paulsen JE; Alexander J
    Mutat Res; 2004 Jan; 557(1):29-40. PubMed ID: 14706516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms.
    Amos-Landgraf JM; Irving AA; Hartman C; Hunter A; Laube B; Chen X; Clipson L; Newton MA; Dove WF
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2060-5. PubMed ID: 22308460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity.
    Haigis KM; Dove WF
    Nat Genet; 2003 Jan; 33(1):33-9. PubMed ID: 12447373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized gene action controlling intestinal neoplasia in mice.
    Gould KA; Dove WF
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5848-53. PubMed ID: 9159163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers.
    Halberg RB; Katzung DS; Hoff PD; Moser AR; Cole CE; Lubet RA; Donehower LA; Jacoby RF; Dove WF
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3461-6. PubMed ID: 10716720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway.
    Halberg RB; Waggoner J; Rasmussen K; White A; Clipson L; Prunuske AJ; Bacher JW; Sullivan R; Washington MK; Pitot HC; Petrini JH; Albertson DG; Dove WF
    Cancer Res; 2009 Jul; 69(14):5768-75. PubMed ID: 19584276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation.
    Andreassen A; Vikse R; Mikalsen A; Adamovic T; Steffensen IL; Hjertholm H; Levan G; Alexander J
    Mutat Res; 2006 Apr; 604(1-2):60-70. PubMed ID: 16574467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.